Also, the upregulation of p14ARF is mainly seen in haematological malignancies (Lee et al, 2003) and in aggressive B-cell lymphomas, and it predicts a shortened survival time (Sanchez-Aguilera et al, 2002). This evidence concerns the gene CDKN2A and B-cell non-Hodgkin lymphoma.